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Abstract
Background: The central paradigm of ecological immunology postulates that selection acts on immunity as to minimize its
cost/benefit ratio. Costs of immunity may arise because the energetic requirements of the immune response divert
resources that are no longer available for other vital functions. In addition to these resource-based costs, mis-directed or
over-reacting immune responses can be particularly harmful for the host. In spite of the potential importance of
immunopathology, most studies dealing with the evolution of the immune response have neglected such non resource-
based costs. To keep the immune response under control, hosts have evolved regulatory pathways that should be
considered when studying the target of the selection pressures acting on immunity. Indeed, variation in regulation may
strongly modulate the negative outcome of immune activation, with potentially important fitness consequences.
Methodology/Principal Findings: Here, we experimentally assessed the survival costs of reduced immune regulation by
inhibiting an anti-inflammatory cytokine (IL-10) with anti-IL-10 receptor antibodies (anti-IL-10R) in mice that were either
exposed to a mild inflammation or kept as control. The experiment was performed on young (3 months) and old (15
months) individuals, as to further assess the age-dependent cost of suppressing immune regulation. IL-10 inhibition
induced high mortality in old mice exposed to the mild inflammatory insult, whereas no mortality was observed in young
mice. However, young mice experienced a transitory lost in body mass when injected with the anti-IL-10R antibodies,
showing that the treatment was to a lesser extent also costly for young individuals.
Conclusions: These results suggest a major role of immune regulation that deserves attention when investigating the
evolution of immunity, and indicate that the capacity to down-regulate the inflammatory response is crucial for late survival
and longevity.
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Introduction
Costs and benefits of the immune response have attracted
considerable attention in the last years among evolutionary
biologists [1–3 for reviews]. Ecological immunology considers
the immune response as a trait whose expression should be
optimized by natural selection as to maximize fitness. Therefore,
the central paradigm of ecological immunology follows an
economical perspective and postulates that immune defences are
beneficial, but also costly, and that natural selection should
minimize the ratio between costs and benefits [2,3]. Costs occur
when investment into immune defences is afforded at the expense
of other fitness-related functions, generating trade-offs between
competing traits [1,2]. Most ecological immunology studies have
focused on such resource-based costs of immunity [4,5], and with a
few exceptions [6–9], have neglected resource independent costs.
This is surprising, given the potentially devastating costs of
autoimmunity. Indeed, the immune system can be depicted as a
two-edged sword where one edge protects against infectious
diseases and the other edge exposes to the risk of misdirected or
over-reacting immune responses [10]. This phenomenon is
generally called immunopathology and illustrates the process of
immune system attacking self-structures of the host. Classical
examples of immunopathology are those due to inflammation, a
crucial component of the immune system. Several diseases arise as
collateral undesirable short-term or delayed outcomes of acute and
chronic inflammation, especially in advanced age [11–14].
Since an over-reacting immune response, or a response failing
to make a distinction between self and non-self, potentially
generates substantial fitness costs, organisms have evolved
regulatory mechanisms based on cells and effectors whose function
is to control the immune system and dampen the negative
consequences of its activation. Therefore, in addition to the
selection pressures acting on the allocation pattern of energy/
resources to immune organs and cells, it seems plausible to expect
strong selection on the regulatory mechanisms that prevent the
system to get out of control. However, in spite of its importance,
immune regulation has been neglected in studies devoted to the
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to assess the cost of suppressing the regulatory mechanisms
underlying the control of the inflammatory response.
Inflammation is a non-specific process characterized by the
delivery of effectors from the blood into infected tissues, and whose
function is to fend off invading pathogens. At the systemic level,
the inflammatory response induces fever, an increased number of
leucocytes recruited for defence, and elevated levels of pro-
inflammatory cytokines driving the microbicidal activity of
phagocytic cells [10]. This category of immune cells produces
cytotoxic compounds such as enzymes, lytic peptides or reactive
oxygen and nitrogen species that kill pathogens [15,16].
Inflammation is characterized by its rapidity (it occurs within
minutes and hours after the encounter with a pathogen) and
endows organisms with potent weapons to cope with infection.
The most compelling support to this view is the high sensitivity to
infection, and the drastically shortened survival prospect, of
organisms with a defective inflammatory response [15]. However,
because the compounds delivered during the inflammatory
response do not discriminate between host and pathogen
structures, they can potentially damage host’s cells and tissues.
Therefore, an over-expressed or misdirected inflammation may
also inflict collateral damage to the host, and there is now
extensive evidence showing that the cost of infection may be due to
inflammatory-borne damage more than to a direct effect of the
pathogen [17,18].
To protect their structures from inflammatory injury, hosts have
evolved regulatory mechanisms based on specific cytokines (e.g.,
interleukin-10, IL-10) controlling the resolution of inflammation.
There exists a polymorphism in genes that code for such
regulatory mechanisms [19,20] and environmental effects (such
as pathogen exposure, individual age) can, as well, shape the
pattern of immune regulation.
In this study, we inhibited an anti-inflammatory cytokine in
order to assess the cost of reduced immune regulation in mice. We
used a full factorial design with three factors: suppression of an
anti-inflammatory cytokine [injection of anti-IL-10 receptor
antibodies (anti-IL-10R) vs. rat IgG1 antibodies (IgG)], stimulation
of the inflammatory response [injection of an E. coli lipopolysac-
charide solution (LPS) vs. phosphate buffered solution (PBS)
injection], age (3 vs. 15 month old).
Materials and Methods
Ethics Statement
The experiment has been conducted in compliance and has
received the agreement of the Animal Care and Ethical
Committee of the Universite ´ de Bourgogne, Dijon (protocol #
6904).
Animals and reagents
Sixty young (3 months old) and sixty old (15 months old) virgin
male C57BL/6 mice were purchased from Janvier (Laval, France).
Upon arrival at the laboratory, animals were individually housed
in Plexiglas cages and kept in an air-conditioned room
(temperature 2161uC, relative humidity 60610%) with a 12-
hours light/dark cycle. Pellet food and tap water were provided ad
libitum.
Treatment procedure
Young and old mice were randomly assigned to one of four
groups (15 individuals per treatment). At day 0, the group ‘‘anti-
IL-10R’’ received an intraperitoneal injection of 20 mgo f
monoclonal anti-IL-10 receptor antibodies (1B1.3a; BD PharMin-
gen), whereas the group ‘‘IgG’’ received an intraperitoneal
injection of 20 mg of rat IgG1 antibodies (Sigma) for control. At
day 1, half of the males in each group were intraperitoneally
injected with a solution of lipopolysaccharides (LPS) from
Escherichia coli (serotype 055:B5, Sigma) at a dose of 0.05 mg/kg,
whereas the other half were injected with a phosphate buffered
solution (PBS) for control. This LPS dose is more than 500-fold
and 30-fold lower than the 50% lethal dose of LPS in 2-month and
24 month old mice, respectively [21]. No injection was applied at
day 2. This injection scheme was repeated three times, each three
days, and the entire experiment covered a 9 day period.
Blood samples were obtained by retroorbital puncture imme-
diately before the first injection (day 0) and 24 hours after the last
injection (day 8). Body mass (60.1 g) was measured at day 0, 2
and 8. Mortality rate was recorded every day for the duration of
the experiment.
Serum amyloid A quantification
Serum amyloid A (SAA), a protein of the acute phase response,
was quantified using an immunoassay kit (Mouse SAA,
KMA0011, Invitrogen). Coloration of the antibody complexes
was measured with a spectrophotometer (spectramax plus 384,
molecular device) at 450 nm.
Statistical Analyses
Differences in survival rate were analyzed with a Log-rank test.
We also used a log-linear model where in addition to the treatment
we included changes in body mass as a potential predictor of
survival rate. Two 15-month old male died during the first
injection and were therefore removed from the survival analysis.
Generalized linear mixed models were used to assess the effect
of the treatments and age on changes in body mass and SAA, with
individual identity declared as a random variable. We started with
the full model and then we dropped all non significant three- and
two-way interactions. Degrees of freedom were adjusted using the
Satthertwaite method. All the analyses were done with SAS (2001)
[22].
Results
During the course of the experiment no young mice died (0/60),
whereas 9 out of 58 old mice died (Fisher exact test, P=0.0012).
The analysis of the effect of the treatment on the survival was,
therefore, restricted to aged mice. Old individuals treated with
anti-IL-10R and with LPS suffered a substantially higher mortality
rate compared to the other three groups (Log-Rank, x
2
3=17.15,
P=0.0007, Figure 1), with mortality of anti-IL-10R/LPS mice
occurring at days 2 and 3. The log-linear model further revealed
that the interaction between the two treatments was statistically
significant and that changes in body mass during day 0 and 2 did
not predict survival prospects (table 1). Overall, these results show
a strong effect of the suppression of the anti-inflammatory cytokine
in old mice exposed to a mild inflammation, and suggest that
mortality was not directly linked to changes in body mass.
Changes in body mass during the course of the experiment
depended on the interaction between the two treatments and the
interaction between the anti-IL-10R treatment and age (table 2).
As expected, LPS injection induced a quite substantial reduction in
body mass, mass loss being even greater in the anti-IL-10R group
(Fig. 2a). Body mass of PBS injected mice was stable during the
course of the experiment (Fig. 2b).
Anti-IL-10R treated young mice suffered from a reduction in
body mass, whereas control (IgG injected) individuals had stable
body mass (Fig. 3a). On the contrary, the anti-IL-10R treatment
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result is not the consequence of selective disappearance of old mice
with the strongest body mass decrease because i) as shown above,
mortality occurred independently from changes in body mass; ii)
the same results were obtained when restricting the analysis of
body mass variation on day 0 and 2 (i.e., when all mice were still
alive).
Both treatments had a strong effect on the production of the
serum amyloid A (SAA), a protein of the acute phase response
(table 3). The anti-IL-10R injection induced an increased
concentration of plasmatic SAA compared to controls (Fig. 4), as
did the injection of LPS compared to PBS (Fig. 5). Interestingly,
however, age did not modulate the SAA production in response to
the two treatments (table 3).
Discussion
Here, we explored the fitness consequences of inhibiting an anti-
inflammatory cytokine both under a mild inflammatory challenge
and control conditions. Our findings show that suppressing the
anti-inflammatory regulation leads to high mortality. Interestingly,
however mortality only occurred in conjunction with the
activation of the inflammatory response and in aged individuals.
Although the treatment was repeated three times during the
course of the experiment, mortality of LPS/anti-IL-10R treated
mice only occurred following the first injection, suggesting that the
treatment selected individuals with a particular pro- vs. anti-
inflammatory profile [23]. Young individuals also suffered from
the suppression of the immune regulation, since they experienced
a reduction of body mass. However, this body mass loss was
transitory and did not lead to any mortality.
Figure 1. Survival rate of 15 month old mice during the course of the experiment for the two treatments. Empty dots: anti-IL-10R/PBS;
full dots: anti-IL-10R/LPS; empty triangles: IgG/PBS; full triangles: IgG/LPS. None of the 3 month old mice died during the course of the experiment.
doi:10.1371/journal.pone.0012940.g001
Table 1. Log-linear model reporting the effect of the
experimental treatments and body mass variation (percent
variation in body mass between day 0 and day 2) on the
survival rate of 15 months old mice.
Source of variation df x
2 P
Percent variation in body mass 1 0.13 0.7162
Anti-IL-10R vs. IgG (Tr1) 1 4.07 0.0435
LPS vs. PBS (Tr2) 1 0.231 0.6332
Tr1 x Tr2 1 4.28 0.0386
doi:10.1371/journal.pone.0012940.t001
Table 2. Generalized linear mixed model reporting the effect
of the experimental treatments and age on the temporal
variation in body mass (day 0, 2, 8).
Source of variation df F P
Time 2,216 10.41 ,0.0001
Anti-IL-10R vs. IgG (Tr1) 1,114 0.06 0.8048
LPS vs. PBS (Tr2) 1,114 12.21 0.0007
Age 1,114 213.84 ,0.0001
Tr1 x Time 2,216 3.09 0.0476
Tr2 x Time 2,216 41.52 ,0.0001
Age x Time 2,216 1.24 0.2919
Tr1 x Tr2 1,114 0.73 0.3939
Tr1 x Age 1,114 0.86 0.3552
Tr1 x Tr2 x Time 2,216 4.36 0.0140
Tr1 x Age x Time 2,216 3.81 0.0236
Mouse identity was fitted into the model as a random factor as to take into
account the repeated nature of the data.
doi:10.1371/journal.pone.0012940.t002
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that evolution has shaped immune defences through resource-
based trade-offs with other competing crucial traits [2,3], our
findings show that immunopathology can generate substantial
costs, directly impairing survival prospects. Previous work has
already put forward the potential role of autoimmune disorders in
the evolution of immune defences [6–8,24]. However, to our
knowledge, this is the first study showing strong age-dependent
survival cost of immune regulation suppression. This finding
corroborates the view that immune regulation is a key process that
should be considered when investigating the outcome of immune
activation and its effects on host fitness.
Our results show that age is a very important factor affecting the
cost of inhibiting immune regulation. Immunosenescence refers to
the age-associated changes in immune functioning that are
observed in humans and animal models [25,26]. Immunosenes-
cence does not necessarily describe a decline in immune
performance but rather a series of changes in immune effectors
that can finally impair immune protection. Longitudinal studies of
elderly humans have shown that some immune markers can be
reliably used as predictor of short term (2-year) mortality [27].
These markers define the Immune Risk Phenotype (IRP) which is
characterized by a depletion of CD95- virgin T cells and the
expansion of CD28- T cells, resulting in an overall reduced T cell
repertoire in old ages [28]. The IRP is, however, also
characterized by an increase of pro-inflammatory cytokines (such
as IL-6 and TNF-a) and a low grade, chronic inflammation [29].
Our finding that old mice paid a severe cost when the regulation of
the inflammatory response was experimentally impaired is in
agreement with these previous results and further stresses that
increased susceptibility to inflammation is a reliable marker of
immunosenescence.
Figure 2. Temporal change in body mass of mice treated with anti-IL-10R antibodies or IgG. (A) LPS; (B) PBS. The bars represent the mean
6 SE.
doi:10.1371/journal.pone.0012940.g002
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natural selection shapes the optimal investment into immune
defences as to maximize fitness. Over investment into immune
defences might be maladaptive if this diverts resources from other
vital functions; similarly, a too small investment might make hosts
too vulnerable to parasite exploitation. We think that another
dimension has to be added to this simple trade-off. In addition to
the total investment into immunity, selection is likely to strongly
act on how well this function is regulated. Ignoring immune
regulation might, therefore, provide a misleading picture on the
real target of selection. For instance, an individual with a low total
investment into immunity but with poor regulation might pay
higher cost of immune activation than an individual with a huge
allocation into immune defences and a very effective immune
regulation. Clearly, ecological immunology needs to explicitly take
into account immune regulation to better assess the selection
forces acting on immunity.
Cost of reduced immune regulation, as shown in this study,
suggests that natural selection has the potential to mold this trait.
Figure 3. Changes in body mass of mice treated with anti-IL-10R antibodies or IgG. (A) young individuals; (B) old individuals. The bars
represent the mean 6 SE.
doi:10.1371/journal.pone.0012940.g003
Table 3. Generalized linear mixed model reporting the effect
of the experimental treatments and age on the temporal
variation (day 0, and 8) in the plasma concentration of the
serum amyloid A.
Source of variation df F P
Time 1,151 203.88 ,0.0001
Body mass 1,151 0.54 0.4628
Anti-IL-10R vs. IgG (Tr1) 1,151 3.086 0.0814
LPS vs. PBS (Tr2) 1,151 73.55 ,0.0001
Age 1,151 0.36 0.5488
Tr1 x Time 1,151 5.88 0.0165
Tr2 x Time 1,151 93.24 ,0.0001
Body mass at day 0 and 8 was also included as a covariate in the model. Mouse
identity was fitted into the model as a random factor as to take into account the
repeated nature of the data.
doi:10.1371/journal.pone.0012940.t003
Immune Regulation and Survival
PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e12940However, the strength of natural selection progressively declines
with age, because the fraction of old individuals in a given
population is much smaller than of young animals. We used for
our study young adults (3 month old) and old (15 month old) mice.
Fifteen month old mice can be considered old [30], but still not
fully senescent individuals since animals that survived the
experiment were still able to successfully reproduce (Belloni et al.
unpublished). In addition to mortality cost paid by old individuals,
young mice suffered from a transitory loss of body mass. Although
all of them successfully recovered from the body mass reduction, it
should be kept in mind that this occurred in a benign lab
environment with no predators and food ad libitum. Therefore,
overall, we believe that our results indicate that natural selection
likely act on immune regulation.
In this study we focused on one anti-inflammatory cytokine (IL-
10). IL-10 has been extensively studied during the last decade [31].
On one hand, IL-10 plays a crucial role in the resolution of
inflammation and as such reduces the risk of immunopathology
when organisms face an infectious disease. On the other hand, IL-
10 can impede parasite clearance by down-regulating the
inflammatory response. This antagonistic action of IL-10 has
been demonstrated in several studies where experimental
suppression of IL-10 results in better parasite clearance and
increased immune-borne damage [31]. For instance, mice infected
with the malaria parasite Plasmodium chabaudii and whose IL-10 was
experimentally neutralized experienced shorter time to death
compared to infected/IL-10
+ controls, showing that immunopa-
thology substantially contributes to the overall cost of infection in
this system [32]. On the contrary, IL-10 deficient mice infected
with the West Nile virus are better protected from the infection
and enjoy a better survival than control, WNV infected mice [33].
These two examples illustrate how the costs and benefits of
immune regulation are largely affected by the specific pathogens
involved and how the immune system responds to them. However,
to our knowledge, how age modulates the fitness costs and benefits
of immune regulation has been largely overlooked.
To conclude, we report here experimental evidence showing
that immune regulation is crucial for survival in aged individuals
Figure 4. Effect of the anti-IL-10R treatment on the production of plasmatic serum amyloid A. The bars represent the mean 6 SE.
doi:10.1371/journal.pone.0012940.g004
Figure 5. Effect of the LPS treatment on the production of plasmatic serum amyloid A. The bars represent the mean 6 SE.
doi:10.1371/journal.pone.0012940.g005
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opens a novel area of research on the fitness consequences of inter-
individual variation in immune regulation.
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